Ceapro Inc. – Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan...
Helius Medical Technologies, Inc. Company to host call at 4:30pm today NEWTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or...